This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Hidenori Nonaka
Group Leader, Regenerative Medicine Research & Planning Division at Rohto Pharmaceutical Co., Ltd., Japan

Profile

Hidenori Nonaka, Group Leader of the Non-Clinical Research Group, Division of Regenerative Medicine Research & Development at Rohto Pharmaceutical, focuses on the development of cell therapy products using allogenic mesenchymal stem cells (MSC). He received his Ph.D. in Molecular and Cellular Biosciences from the University of Tokyo in 2005. He plays a major role in developing ADR-001, one of our MSC programs which has been under clinical investigation for liver cirrhosis.

Agenda Sessions

  • Critical Quality Attributes & Controls for Cell Therapy Products

    12:50